Detalhe da pesquisa
1.
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(2): 223-234, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539742
2.
Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group.
Br J Haematol
; 193(3): 515-519, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33486762
3.
Relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group.
Blood
; 132(14): 1519-1525, 2018 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30064977
4.
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Lancet
; 390(10114): 2790-2802, 2017 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29061295
5.
Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.
Blood
; 127(18): 2189-92, 2016 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26834240
6.
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group.
Lancet Oncol
; 18(4): 454-463, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28236583
7.
Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group.
Lancet Oncol
; 18(12): 1680-1687, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29133014
8.
Impact of bone marrow involvement on early positron emission tomography response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphoma.
Br J Haematol
; 197(1): e5-e8, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34929056
9.
Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group.
Lancet Oncol
; 17(10): 1453-1462, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27612583
10.
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
Lancet
; 385(9976): 1418-27, 2015 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25539730
11.
Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group.
Blood
; 123(11): 1658-64, 2014 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24478403
12.
Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group.
Br J Haematol
; 171(4): 547-56, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26310520
13.
Current status of prognostication in classical Hodgkin lymphoma.
Br J Haematol
; 165(3): 287-99, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24494650
14.
PI3Kδ inhibitor, GS-1101 (CAL-101), attenuates pathway signaling, induces apoptosis, and overcomes signals from the microenvironment in cellular models of Hodgkin lymphoma.
Blood
; 119(8): 1897-900, 2012 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22210877
15.
An update on emerging drugs for Hodgkin lymphoma.
Expert Opin Emerg Drugs
; 19(2): 215-24, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24749769
16.
Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis.
Lancet Oncol
; 14(10): 943-52, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23948348
17.
Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma.
Leukemia
; 38(1): 160-167, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37845285
18.
Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.
Lancet
; 379(9828): 1791-9, 2012 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22480758
19.
Interleukin-10 gene polymorphisms are associated with freedom from treatment failure for patients with Hodgkin lymphoma.
Oncologist
; 18(1): 80-9, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23299779
20.
Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.
N Engl J Med
; 363(7): 640-52, 2010 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-20818855